146 related articles for article (PubMed ID: 30174420)
1. Social economic costs of COPD in Extremadura (Spain): an observational study.
Merino M; Villoro R; Hidalgo-Vega Á; Carmona C
Int J Chron Obstruct Pulmon Dis; 2018; 13():2501-2514. PubMed ID: 30174420
[TBL] [Abstract][Full Text] [Related]
2. Social economic costs of ankylosing spondylitis in Spain.
Merino M; Braçe O; González-Domínguez A; Hidalgo-Vega Á; Garrido-Cumbrera M; Gratacós J
Clin Exp Rheumatol; 2021; 39(2):357-364. PubMed ID: 32662412
[TBL] [Abstract][Full Text] [Related]
3. Economic analysis of the Confronting COPD survey: an overview of results.
Wouters EF
Respir Med; 2003 Mar; 97 Suppl C():S3-14. PubMed ID: 12647938
[TBL] [Abstract][Full Text] [Related]
4. Social and economic costs and health-related quality of life in stroke survivors in the Canary Islands, Spain.
Lopez-Bastida J; Oliva Moreno J; Worbes Cerezo M; Perestelo Perez L; Serrano-Aguilar P; Montón-Álvarez F
BMC Health Serv Res; 2012 Sep; 12():315. PubMed ID: 22970797
[TBL] [Abstract][Full Text] [Related]
5. The effect of quitting smoking on costs and healthcare utilization in patients with chronic obstructive pulmonary disease: a comparison of current smokers versus ex-smokers in routine clinical practice.
Sicras-Mainar A; Rejas-Gutiérrez J; Navarro-Artieda R; Ibáñez-Nolla J
Lung; 2014 Aug; 192(4):505-18. PubMed ID: 24816902
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life of patients diagnosed with COPD in Extremadura, Spain: results from an observational study.
Merino M; Villoro R; Hidalgo-Vega Á; Carmona C;
Health Qual Life Outcomes; 2019 Dec; 17(1):189. PubMed ID: 31888646
[TBL] [Abstract][Full Text] [Related]
7. Health economic costs of COPD in Sweden by disease severity--has it changed during a ten years period?
Jansson SA; Backman H; Stenling A; Lindberg A; Rönmark E; Lundbäck B
Respir Med; 2013 Dec; 107(12):1931-8. PubMed ID: 23910072
[TBL] [Abstract][Full Text] [Related]
8. Costs of chronic obstructive pulmonary disease in relation to compliance with guidelines: a study in the primary care setting.
Miravitlles M; Sicras A; Crespo C; Cuesta M; Brosa M; Galera J; Lahoz R; Lleonart M; Riera MI
Ther Adv Respir Dis; 2013 Jun; 7(3):139-50. PubMed ID: 23653458
[TBL] [Abstract][Full Text] [Related]
9. Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries.
Foo J; Landis SH; Maskell J; Oh YM; van der Molen T; Han MK; Mannino DM; Ichinose M; Punekar Y
PLoS One; 2016; 11(4):e0152618. PubMed ID: 27092775
[TBL] [Abstract][Full Text] [Related]
10. Cost of Patients with Alzheimer's Disease in Spain According to Disease Severity.
Gómez Maldonado L; de Mora-Figueroa R; López-Angarita A; Maravilla-Herrera P; Merino M
Pharmacoecon Open; 2024 Jan; 8(1):103-114. PubMed ID: 37966711
[TBL] [Abstract][Full Text] [Related]
11. Economic impact of patients admitted to stroke units in Spain.
Alvarez-Sabín J; Quintana M; Masjuan J; Oliva-Moreno J; Mar J; Gonzalez-Rojas N; Becerra V; Torres C; Yebenes M;
Eur J Health Econ; 2017 May; 18(4):449-458. PubMed ID: 27084749
[TBL] [Abstract][Full Text] [Related]
12. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
[TBL] [Abstract][Full Text] [Related]
13. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
[TBL] [Abstract][Full Text] [Related]
14. Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A; Kanavos P; López-Bastida J; Linertová R; Nicod E; Serrano-Aguilar P;
BMC Health Serv Res; 2015 Sep; 15():428. PubMed ID: 26416027
[TBL] [Abstract][Full Text] [Related]
15. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
Hong YD; Onukwugha E; Slejko JF
J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
[TBL] [Abstract][Full Text] [Related]
16. The burden of COPD in Spain: results from the Confronting COPD survey.
Izquierdo JL
Respir Med; 2003 Mar; 97 Suppl C():S61-9. PubMed ID: 12647944
[TBL] [Abstract][Full Text] [Related]
17. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
[TBL] [Abstract][Full Text] [Related]
18. Social economic costs and health-related quality of life in patients with systemic sclerosis in Spain.
López-Bastida J; Linertová R; Oliva-Moreno J; Posada-de-la-Paz M; Serrano-Aguilar P
Arthritis Care Res (Hoboken); 2014 Mar; 66(3):473-80. PubMed ID: 24022829
[TBL] [Abstract][Full Text] [Related]
19. The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study.
Delgado-Ortega L; González-Domínguez A; Borrás JM; Oliva-Moreno J; González-Haba E; Menjón S; Pérez P; Vicente D; Cordero L; Jiménez M; Simón S; Hidalgo-Vega Á; Moya-Alarcón C
Eur J Health Econ; 2019 Feb; 20(1):135-147. PubMed ID: 29922900
[TBL] [Abstract][Full Text] [Related]
20. Costs of depression in Catalonia (Spain).
Salvador-Carulla L; Bendeck M; Fernández A; Alberti C; Sabes-Figuera R; Molina C; Knapp M
J Affect Disord; 2011 Jul; 132(1-2):130-8. PubMed ID: 21402411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]